Cosentyx snrdy 300MG dose-2PENML
Ended Awarded
- Contract number
- SPE2DB25FYBTB
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $15,483
Award facts
- Contract value 100% obligated
- $15,482.56 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $15,482.56 to AmerisourceBergen Drug Corp for Cosentyx (secukinumab) 300mg dose in 2ml pen form. This award, made on August 18, 2025, represents a firm fixed-price delivery order with an ultimate completion date of August 19, 2025, and carries no set-aside designation. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters and primary distribution operations. As a leading pharmaceutical distributor and critical vendor for federal medical procurement, AmerisourceBergen supplies a comprehensive portfolio of medications and medical supplies to support military and veteran healthcare systems.
This delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.999 billion prime vendor agreement running through December 2026 that supports global pharmaceutical supply chains for the Department of Defense. The contract vehicle enables the company to supply an extensive range of pharmaceuticals, vaccines, and medical devices across multiple therapeutic domains to support military healthcare programs worldwide, including services to the Defense Health Agency and U.S. Coast Guard. All of AmerisourceBergen's reviewed federal contract awards have been competitively awarded without set-aside provisions, demonstrating the company's capability to meet federal procurement requirements in open competition.
Quick answers
Who was awarded contract SPE2DB25FYBTB?
SPE2DB25FYBTB was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 18, 2025.
How much is contract SPE2DB25FYBTB worth?
The government has obligated $15,483 on SPE2DB25FYBTB.
Is contract SPE2DB25FYBTB an order under another contract?
Yes. SPE2DB25FYBTB is a delivery order under SPE2DB20D3505, an indefinite delivery contract.
Was contract SPE2DB25FYBTB competed?
The extent of competition for SPE2DB25FYBTB was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award